Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Mid-range Performer
1098.0000 11.90 (1.10%)
NSE Oct 09, 2025 15:31 PM
Volume: 68,188
 

logo
Jubilant Pharmova Ltd.
10 May 2018
1098.00
1.10%
buy
Results Update: Jubilant Pharmova Ltd.
by HDFC Securities
HDFC Securities
Revenue rose by 8.93% to Rs. 2223.77 Cr in Q4FY18 when compared to the previous quarter. Jubilant Life Sciences Ltd Q4FY18 results Comment
 
Number of FII/FPI investors increased from 196 to 233 in Jun 2025 qtr.
More from Jubilant Pharmova Ltd.
Recommended
Market closes higher, L&T bags an order worth over Rs 15,000 crore
Trendlyne Marketwatch | 09 Oct 2025, 04:08PM
Diamonds in the dust: Who's thriving in a tough Q2 earnings season?
The Baseline | 09 Oct 2025, 02:29PM
Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences
| 30 May 2020